CompoAtlas

Sabadilla B

Natural health product licensed in Canada

Other names
Enfants 0-9 Sabadilla B, Enfants 0-9 Sabadilla+, Sabadilla+, kids 0-9 Sabadilla B, kids 0-9 Sabadilla+
Licence holder
Homeocan Inc.
NPN or DIN-HM
80085305
Status
Active licence
Licence date
16 May 2018
Revision date
Not provided
Form
Liquide oral, solution
Route of administration
Orale
Application type
Homéopathique

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Kali bichromicum

Source : Dichromate de potassium

3 CHNot calculated
Belladonna

Source : Plante entière lorsqu'elle commence à fleurir

3 CHNot calculated

Non-medicinal ingredients

Eau purifiée

PopulationAgeQuantity per servingFrequency
Enfantsminimum: 4 months ; maximum: 11 months1 dose unitaire3 days

Uses authorised in Canada

Médicament homéopathique pour les symptômes du rhume tels que: l'écoulement nasal, les éternuements, la congestion nasale, les rhinites aigues, à répétition, infectueuses ou allergiques, les frissons et la fièvre modérée. AVERTISSEMENT - Cette allégation est fondée sur des références homéopathiques traditionnelles et non sur des preuves scientifiques modernes.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80085305

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line